
Chinese medical isotope company in Shenzhen, Guangdong, part of the PanMediso group, aiming to become a leading global supplier of medical isotopes and to break the country's long-standing dependence on imported isotope technology and capacity. Works across research, production and sales of isotopes including GMP grade Ge-68 and Ac-225 for global supply, announced a breakthrough in key Ac-225 production technology in London in August 2024, and also offers CDMO services for radiopharmaceuticals from laboratory scale through to large scale commercial manufacture.
評価を残す